References
- Department of Health and Social Security. Sharing Resowres for Health in England. The Report of the Resource Allocation Working Party (The RAWP Report). HMSO London, UK (1976).
- Eddy D. Cost-effectiveness analysis — is it up to the task? JAIVIA 267(24), 3342–3348 (1992).
- Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Healthcare Financ. Rev 7 (1), 61–80 (1985).
- The Global Burrlen of Disease. Murray CJL, Lopez AD, (Eds). Harvard University Press, Boston, MA, USA (1996).
- •This volume forms part of the Global Burden of Disease and Injury Series, a worldwide collaboration sponsored by the World Health Organization and the World Bank, based at the Harvard School of Public Health. This volume contains an assessment of mortality and disability from diseases, injuries and risk-factors in 1990 and projected to 2020. The authors present the methodology for estimating disability-adjusted life years (DALY) that has been replicated in many other studies.
- World Bank. World Development Report 1993: Investing in Health, Oxford University Press, NY, USA (1993).
- •Examines the relationship between healthcare and health policy It applies the methods of the Global Burden of Disease Study, concentrating on developing countries and formerly socialist countries. The report recommends reforms that aim to improve the length and quality of lives of the poorest people of the world. The use of DALYs to estimate the burden of disease highlights areas of greatest need and exploratory use is made of the concept of cost per DALY averted.
- Nord E. The person-trade-off approach to valuing healthcare programs. Med Decis. IVIaking15(3), 201–208 (1995).
- Little IMD. A Critique of Wlfatr Economics. Oxford University Press, Oxford, UK, 84–97 (1973).
- Hausman DM, McPherson MS. Efficiency. In: Economic Analysis and Moral Philosophy Cambridge University Press, Cambridge, UK, 84–100 (1996).
- Williams A. Economics of coronary artery bypass grafting. BE Med 291,326–329 (1985).
- Drummond ME, O'Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Healthcare, Second Edition. Oxford University Press, Oxford, UK (1997).
- •The standard textbook in the field of economic evaluation. It outlines the key methodological principles and provides a framework for critical appraisal. A chapter on cost—utility analysis includes a section on deriving quality-adjusted life year (QALY), how they can be used and difficulties to be addressed.
- Torrance GW, Zipursky A. Cost- effectiveness of antepartum prevention of Rh immunization. Clin. Perinatal 11 (2), 267–281 (1984).
- Schulman IKA, Lynn LA, Glick HA, Eisenberg JM. Cost-effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 114(9), 798–802 (1991).
- Laupacis A, Feeny D, Detsky AS, Tugswell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146(4), 473–481 (1992).
- Harris A, Buxton M, O'Brien B, Rutten F, Drummond M. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. Expert Rev. Pharmacoeconomics Outcomes Res. 1(1), 7–12 (2001).
- Hadorn DC. Setting healthcare priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAIVIA 265(17), 2218–2225 (1991).
- Eddy D. Oregon's methods. Did cost-effectiveness analysis fail? JAIVIA 266(15), 2135–2141 (1991).
- Tengs TO. An evaluation of Oregon's Medicaid rationing algorithms. Health Economics5, 170–181 (1996).
- Melse JM, Essink-Bot ML, Kramers PG, Hoeymans N. A national burden of disease calculation: Dutch Burden of Disease Group. Am. Public Health 90(8), 1241–1247 (2000).
- Wijewardene K, Spohr M. An attempt to measure burden of disease using disability adjusted life years for Sri Lanka. Ceylon Med 45(3), 110–115 (2000).
- Kissimova-Skarbeck K, Pach D, Placzkiewicz E, Szurkowska M, Szybinski Z. Evaluation of burden of diabetes in Poland. Pol. Arch. Med. Wwn. 106(3), 867–873 (2001).
- Pang L, Jin S, Song G. A study on methods to measure the social burden of disease and their significance. Zhonghua Yu Fang- Yi Xue Za Zhi 34(4), 218–220 (2000).
- Xu Q, Jin SG, Zhang LX. Estimation of burden of disease for smear-positive pulmonary TB and its infectivity. Domed. Environ. Sci. 13(2), 140–147 (2000).
- Schopper D, Pereira J, Torres A et al Estimating the burden of disease in one Swiss canton: what do disability adjusted life years (DALYs) tell us? Int. J. Epidemiol 29(5), 871–877 (2000).
- Fox-Rushby JA. DisabilityAdjusted Life Yeats OALYs) for dEcision-makine An Overview of The Literature. Office of Health Economics, London, UK (2002).
- •Examines the pros and cons of basing decisions on disability-adjusted life years (DALYs), based on a systematic review of the published literature. This review the background to and construction of DALYs, how they have been used to inform decision-making and includes a summary of critiques of the paradigm. In the discussion, the author compares the use of QALYs and DALYs.
- Donaldson C, Mooney G. Needs assessment, priority setting and contracts for healthcare: an economic overview. BE Med 303,1529–1530 (1991).
- Mooney G. Key Issues in Health Economics. Harvester Wheatsheaf, NY, USA (1994).
- Donaldson C. Economics, public health and healthcare purchasing. Health Policy33 (2), 79–90 (1995).
- Williams A. Calculating the global burden of disease: time for a strategic reappraisal. Health Econ. 8(1), 1–8 (1999).
- Murray CJL, Evans DB, Acharya A, Baltussen RMPB. Development of WHO guidelines on generalised cost-effectiveness analysis. Health Econ. 9 (3), 235–251 (2000).
- Birch S, Donaldson C. Applications of cost—benefit analysis to healthcare: departures from welfare economic theory. Health Econ. 6(3), 211–225 (1987).
- Birch S, Gafni A. Cost-effectiveness/utility analyses: do current decision rules lead us to where we want to be?j Health Econ. 11(3), 279–296 (1992).
- Birch S, Gafni A. Changing the problem to fit the solution: Johannesson and Weinstein's (mis)application of economics to real world problems. J. Health Econ. 12(4), 469–476 (1993).
- Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of healthcare resources. J. Health Econ. 15(5), 641–653 (1996).
- Hollinghurst S, Bevan G, Bowie C. Estimating the avoidable burden of disease by Disability Adjusted Life Years (DALYs). Healthcare Manag. Sci. 3(1), 9–21 (2000).
- •Distinguishes between the total burden of disease and the avoidable burden of disease, which is the part that can be addressed with current knowledge and technology. They describe their methods of estimating avoidable DALYs and how they applied the methods to seven causes of death and disability in the south and west Region. The discussion considers the relevance of this work for monitoring the health of populations and deciding how best to use scarce resources to improve health.
- Secretary of State for Health. National Service Framework for Comnary Heart Disease. The Stationery Office, London, UK (2000).
- Robinson R. Limits to rationality: economics, economists and priority setting. Health Policy 49(1-4 13–26 (1999).
- Kuhn TS. The Structure of ScientifIc Revaluations. University of Chicago Press, Chicago, IL, USA (1962).
- Holland WW (Ed.). European Community Atlas of Avoidable Death. Vol. 1. Oxford University Press, Oxford, UK (1991).
- Stevens A, Raftery J (Eds). Healthcare needs assessment. The epidemiolgically based needs assessment reviews. Radcliffe Medical Press, Oxford, UK (1994).
- Sanderson CF, Hunter DJ, McKee CM, Black NA. Limitations of epidemiologically based needs assessment. The case of prostatectomy. Medical Care 35 (7), 669–685 (1997).
Websites
- www.aihw.gov.au/pophealth/burden.html (Accessed 8 May 2003). Australian Institute of Health and Welfare. Burden of Disease Database.
- www.dhs.vic.gov.au/phd/bod/index.htm (Accessed 8 May 2003). Government of Victoria, Australia, Department of Human Services. Victorian Burden of Disease Study.